Event Type
Disclosure
Voluntary
Variant
8-K
Other Events On June 26, 2025, Theravance Biopharma, Inc. (“Theravance Biopharma” or the “Company”) (NASDAQ: TBPH) announced that Viatris, Inc. (“Viatris”) has
. Financial Statements and Exhibits. (d) Exhibits. 99.1 Press Release dated June 26, 2025 104 Cover Page Interactive Data File (cover page XBRL tags embedded wi